Home > Insider Trading > Filing (0000313143-13-000098)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
313143	Haemonetics Corp	HAE	Surgical & Medical Instruments & Apparatus (3841)	042882273

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1266051	J Christopher Lindop	400 Wood Road Braintree MA 02184	Cfo & Evp Business Development	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-06-18	68,628	$26.32	99,042	No	4	M	Direct
Common Stock	Disposition	2013-06-18	68,628	$42.50	30,414	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2013-06-18	68,628	$0.00	68,628	$26.32

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
29,412	2009-10-23	2015-10-23	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Non-Qualified Stock Option (right to buy)	$26.47	2010-10-27	2016-10-27	44,072	44,072	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$27.50	2011-10-27	2017-10-27	50,190	50,190	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$30.67	2012-10-25	2018-10-25	48,306	48,306	Direct
Common Stock	Non-Qualified Stock Option (right to buy)	$39.06	2013-10-24	2019-10-24	46,498	46,498	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2016-10-27	44,072	44,072	Direct
2017-10-27	50,190	50,190	Direct
2018-10-25	48,306	48,306	Direct
2019-10-24	46,498	46,498	Direct

Footnotes

Pursuant to a 10b5-1 Plan.
The Form 4 dated May 24, 2013 incorrectly reported the total amount of Securities Beneficially Owned Following the Reported Transaction as 31,110 shares. This Form 4 correctly reports the information. Total includes Restricted Stock Awards and/or Restricted Stock Units that are subject to restrictions until vesting requirements are met. Grant was made under 2005 Long Term Incentive Compensation Plan.
Grant to reporting person of right to buy shares of common stock vesting in annual increments over a 5 year period beginning on the first anniversary of the date of grant.
Grant to reporting person of right to buy shares of common stock exercisable in annual increments of 25 percent beginning on the first anniversary of the date of grant.